Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy

NCT07359963 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Regend Therapeutics